Kenneth Bloom

An early adopter of information technology, Kenneth developed the first commercial telepathology system during his residency. Creator of the Pathology Information System at Rush Medical Center, he also helped design the hospital’s Tumor Registry and Surgical Information System. His career spans more than 30 years, including key positions in start-up companies, University-based medical centers and commercial laboratories. An author of more than 50 peer-reviewed articles, he has also served as principal investigator of more than a dozen clinical trials. Currently, he is President and CEO of Clarient Pathology Services, and Chief Medical Officer of Clarient Diagnostic Services, where his lab evaluates over 100 breast cancers daily.

Content by Kenneth Bloom:

Outside the Lab Oncology

Not Reflective of Clinical Practice

04/28/2015 | Kenneth Bloom

Although the JAMA article (1) claims to have identified a lack of consistency in pathologists’ breast cancer diagnoses, this doesn’t reflect actual clinical practice